EurekAlert! -
14 Apr 2019 08:00
(Institute of Cancer Research) Cancers can make themselves harder for new immunotherapies to see by 'changing their spots' -- and switching off a key molecule on the surface of cells that is otherwise recognised by treatment.
Share this Article